Stem cell therapy: a promising frontier in modern medicine with a comprehensive overview of their biology and potential therapeutic applications in chronic non-healing cutaneous injuries.

IF 5.3 2区 医学 Q2 IMMUNOLOGY
Qadeer Ahmad, Shumaila Mehdi, Malik Hassan Mehmood, Muhammad Talha Asif, Muhammad Mohsin Ali
{"title":"Stem cell therapy: a promising frontier in modern medicine with a comprehensive overview of their biology and potential therapeutic applications in chronic non-healing cutaneous injuries.","authors":"Qadeer Ahmad, Shumaila Mehdi, Malik Hassan Mehmood, Muhammad Talha Asif, Muhammad Mohsin Ali","doi":"10.1007/s10787-025-01924-6","DOIUrl":null,"url":null,"abstract":"<p><p>Chronic wounds represent significant challenges to the healthcare system. Their incidence increases with increase in age, especially in individuals suffering from chronic disorders like diabetes. The process of wound healing consists of a series of coordinated biological events triggered by tissue damage, ultimately leading to the repair and restoration of damaged tissues. Various pharmacological and non-pharmacological interventions are employed for the management of chronic wounds. The clinical application of traditional therapeutic modalities for managing chronic wounds is limited due to the associated adverse effects, like antimicrobial resistance, pressure lesions, ear and nose barotrauma, and convulsions. Recent advancements in stem cell therapy hold promise for the management of chronic wounds. These are the undifferentiated cells of the human body with the capability of self-renewal. These cells migrate to the wounded site and transform into the required type of cell to repair the tissues. The use of autologous stem cells decreases the risk of immune rejection and infections. These cells do not carry the risk of transmitting contagious diseases from the donor. Various types of stem cells have been investigated in the management of chronic wounds using diverse modes. These cells can be administered topically on the wounded site or through various matrices, such as hydrogels, scaffolds, extracellular matrix derivatives, and dermal substitutes. These cells promote the healing process by acting directly or indirectly on various pathogenic targets in chronic wounds. This review aims to explore the potential of stem cells in chronic wound management, including diabetic foot ulcers, burn ulcers, pressure ulcers, inherited epidermolysis bullosa, and venous leg ulcers. This review also highlights the molecular and cellular pathways involved in wound healing discussed in this review. Moreover, various pre-clinical and clinical studies exploring the use of stem cells in chronic wounds are also reviewed. In sum, the current review weighs the limitations associated with traditional therapies and the merits of the potential application of stem cells in chronic wound management.</p>","PeriodicalId":13551,"journal":{"name":"Inflammopharmacology","volume":" ","pages":""},"PeriodicalIF":5.3000,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Inflammopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10787-025-01924-6","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Chronic wounds represent significant challenges to the healthcare system. Their incidence increases with increase in age, especially in individuals suffering from chronic disorders like diabetes. The process of wound healing consists of a series of coordinated biological events triggered by tissue damage, ultimately leading to the repair and restoration of damaged tissues. Various pharmacological and non-pharmacological interventions are employed for the management of chronic wounds. The clinical application of traditional therapeutic modalities for managing chronic wounds is limited due to the associated adverse effects, like antimicrobial resistance, pressure lesions, ear and nose barotrauma, and convulsions. Recent advancements in stem cell therapy hold promise for the management of chronic wounds. These are the undifferentiated cells of the human body with the capability of self-renewal. These cells migrate to the wounded site and transform into the required type of cell to repair the tissues. The use of autologous stem cells decreases the risk of immune rejection and infections. These cells do not carry the risk of transmitting contagious diseases from the donor. Various types of stem cells have been investigated in the management of chronic wounds using diverse modes. These cells can be administered topically on the wounded site or through various matrices, such as hydrogels, scaffolds, extracellular matrix derivatives, and dermal substitutes. These cells promote the healing process by acting directly or indirectly on various pathogenic targets in chronic wounds. This review aims to explore the potential of stem cells in chronic wound management, including diabetic foot ulcers, burn ulcers, pressure ulcers, inherited epidermolysis bullosa, and venous leg ulcers. This review also highlights the molecular and cellular pathways involved in wound healing discussed in this review. Moreover, various pre-clinical and clinical studies exploring the use of stem cells in chronic wounds are also reviewed. In sum, the current review weighs the limitations associated with traditional therapies and the merits of the potential application of stem cells in chronic wound management.

干细胞治疗:现代医学的一个有前途的前沿,全面概述了它们的生物学和潜在的治疗应用于慢性非愈合皮肤损伤。
慢性伤口是对医疗保健系统的重大挑战。它们的发病率随着年龄的增长而增加,特别是在患有糖尿病等慢性疾病的个体中。创面愈合过程是由组织损伤引发的一系列协调的生物事件,最终导致受损组织的修复和恢复。各种药物和非药物干预措施被用于慢性伤口的管理。由于相关的不良反应,如抗菌素耐药性、压力损伤、耳鼻部气压伤和抽搐,传统治疗方式在慢性伤口治疗中的临床应用受到限制。干细胞治疗的最新进展为慢性伤口的治疗带来了希望。这些是人体内具有自我更新能力的未分化细胞。这些细胞迁移到受伤部位并转化为修复组织所需的细胞类型。自体干细胞的使用降低了免疫排斥和感染的风险。这些细胞不携带从供体传播传染病的风险。各种类型的干细胞已被研究在慢性伤口的管理使用不同模式。这些细胞可以局部施用于受伤部位或通过各种基质,如水凝胶、支架、细胞外基质衍生物和真皮替代品。这些细胞通过直接或间接作用于慢性伤口的各种致病靶点来促进愈合过程。本综述旨在探讨干细胞在慢性伤口管理中的潜力,包括糖尿病足溃疡、烧伤溃疡、压疮、遗传性大疱性表皮松解症和静脉性腿溃疡。这篇综述也强调了分子和细胞途径参与伤口愈合的讨论。此外,各种临床前和临床研究探索干细胞在慢性伤口的使用也进行了回顾。总之,目前的综述权衡了与传统疗法相关的局限性和干细胞在慢性伤口治疗中的潜在应用的优点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Inflammopharmacology
Inflammopharmacology IMMUNOLOGYTOXICOLOGY-TOXICOLOGY
CiteScore
8.00
自引率
3.40%
发文量
200
期刊介绍: Inflammopharmacology is the official publication of the Gastrointestinal Section of the International Union of Basic and Clinical Pharmacology (IUPHAR) and the Hungarian Experimental and Clinical Pharmacology Society (HECPS). Inflammopharmacology publishes papers on all aspects of inflammation and its pharmacological control emphasizing comparisons of (a) different inflammatory states, and (b) the actions, therapeutic efficacy and safety of drugs employed in the treatment of inflammatory conditions. The comparative aspects of the types of inflammatory conditions include gastrointestinal disease (e.g. ulcerative colitis, Crohn''s disease), parasitic diseases, toxicological manifestations of the effects of drugs and environmental agents, arthritic conditions, and inflammatory effects of injury or aging on skeletal muscle. The journal has seven main interest areas: -Drug-Disease Interactions - Conditional Pharmacology - i.e. where the condition (disease or stress state) influences the therapeutic response and side (adverse) effects from anti-inflammatory drugs. Mechanisms of drug-disease and drug disease interactions and the role of different stress states -Rheumatology - particular emphasis on methods of measurement of clinical response effects of new agents, adverse effects from anti-rheumatic drugs -Gastroenterology - with particular emphasis on animal and human models, mechanisms of mucosal inflammation and ulceration and effects of novel and established anti-ulcer, anti-inflammatory agents, or antiparasitic agents -Neuro-Inflammation and Pain - model systems, pharmacology of new analgesic agents and mechanisms of neuro-inflammation and pain -Novel drugs, natural products and nutraceuticals - and their effects on inflammatory processes, especially where there are indications of novel modes action compared with conventional drugs e.g. NSAIDs -Muscle-immune interactions during inflammation [...]
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信